Literature DB >> 12143430

Escherichia coli O157:H7: etiology, clinical features, complications, and treatment.

E Peacock1, V W Jacob, S M Fallone.   

Abstract

In recent years, Escherichia coli (E. coli) O157:H7 has developed into an emerging cause of foodborne illness. It has been identified as the leading cause of post-diarrheal hemolytic-uremic syndrome (HUS) and acute renal failure in infancy and childhood. This article examines, the etiology, clinical features, complications, and treatment of this illness. Prevention strategies are also presented as well as a disaster management case study.

Entities:  

Mesh:

Year:  2001        PMID: 12143430

Source DB:  PubMed          Journal:  Nephrol Nurs J        ISSN: 1526-744X            Impact factor:   0.959


  6 in total

1.  Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157:H7 levels in sheep guts.

Authors:  Raul R Raya; Rebecca A Oot; Ben Moore-Maley; Serena Wieland; Todd R Callaway; Elizabeth M Kutter; Andrew D Brabban
Journal:  Bacteriophage       Date:  2011-01

Review 2.  Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Nephrol       Date:  2013-08-06

3.  Syntaxin 16 and syntaxin 5 are required for efficient retrograde transport of several exogenous and endogenous cargo proteins.

Authors:  Mohamed Amessou; Alexandre Fradagrada; Thomas Falguières; J Michael Lord; Daniel C Smith; Lynne M Roberts; Christophe Lamaze; Ludger Johannes
Journal:  J Cell Sci       Date:  2007-03-27       Impact factor: 5.285

4.  A diagnosis of haemolytic-uraemic syndrome blurred by alcohol abuse.

Authors:  Martin Killian; Noémie Bruel Tronchon; Nicolas Maillard; Bernard Tardy
Journal:  BMJ Case Rep       Date:  2014-12-24

5.  Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010.

Authors:  Hassan Vally; Gillian Hall; Amalie Dyda; Jane Raupach; Katrina Knope; Barry Combs; Patricia Desmarchelier
Journal:  BMC Public Health       Date:  2012-01-21       Impact factor: 3.295

Review 6.  Management strategies in the treatment of neonatal and pediatric gastroenteritis.

Authors:  Simona Ciccarelli; Ilaria Stolfi; Giuseppe Caramia
Journal:  Infect Drug Resist       Date:  2013-10-29       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.